Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan A Grupp

Showing results (31-40 of 238) with videos related to

Pageof 24
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2008
Immunotherapy for pediatric cancerStephan A Grupp, Michael Verneris, Paul M Sondel, et al.
Journal of Hematology & Oncology|March 4, 2018
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucelDavid Porter, Noelle Frey, Patricia A Wood, et al.
Nature Reviews. Clinical Oncology|February 14, 2018
Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'David T Teachey, Michael R Bishop, David G Maloney, et al.
Blood|May 23, 2015
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemiaShannon L Maude, David T Teachey, David L Porter, et al.
Blood Advances|October 1, 2020
Lingering effects of chemotherapy on mature T cells impair proliferationRajat K Das, Roddy S O'Connor, Stephan A Grupp, et al.
Blood|November 25, 2003
RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapyChristina M Coughlin, Barbara A Vance, Stephan A Grupp, et al.
Blood|March 1, 2014
Antibody-modified T cells: CARs take the front seat for hematologic malignanciesMarcela V Maus, Stephan A Grupp, David L Porter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2012
The future is now: chimeric antigen receptors as new targeted therapies for childhood cancerDaniel W Lee, David M Barrett, Crystal Mackall, et al.
Cancer Research|August 3, 2002
Cytoplasmic micro heavy chain confers sensitivity to dexamethasone-induced apoptosis in early B-lineage acute lymphoblastic leukemiaJenny M Kim, Junjie Fang, Susan Rheingold, et al.
Immunologic Research|July 15, 2003
Role of the BCR complex in B cell development, activation, and leukemic transformationSusan R Rheingold, Valerie I Brown, Junjie Fang, et al.
Pageof 24

Showing results (31-40 of 238) with videos related to

Sort By:
Pageof 24
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2008
Immunotherapy for pediatric cancerStephan A Grupp, Michael Verneris, Paul M Sondel, et al.
Journal of Hematology & Oncology|March 4, 2018
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucelDavid Porter, Noelle Frey, Patricia A Wood, et al.
Nature Reviews. Clinical Oncology|February 14, 2018
Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'David T Teachey, Michael R Bishop, David G Maloney, et al.
Blood|May 23, 2015
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemiaShannon L Maude, David T Teachey, David L Porter, et al.
Blood Advances|October 1, 2020
Lingering effects of chemotherapy on mature T cells impair proliferationRajat K Das, Roddy S O'Connor, Stephan A Grupp, et al.
Blood|November 25, 2003
RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapyChristina M Coughlin, Barbara A Vance, Stephan A Grupp, et al.
Blood|March 1, 2014
Antibody-modified T cells: CARs take the front seat for hematologic malignanciesMarcela V Maus, Stephan A Grupp, David L Porter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2012
The future is now: chimeric antigen receptors as new targeted therapies for childhood cancerDaniel W Lee, David M Barrett, Crystal Mackall, et al.
Cancer Research|August 3, 2002
Cytoplasmic micro heavy chain confers sensitivity to dexamethasone-induced apoptosis in early B-lineage acute lymphoblastic leukemiaJenny M Kim, Junjie Fang, Susan Rheingold, et al.
Immunologic Research|July 15, 2003
Role of the BCR complex in B cell development, activation, and leukemic transformationSusan R Rheingold, Valerie I Brown, Junjie Fang, et al.
Pageof 24